Sajjad Ahmad, Deputy Business Editor

The UAE healthcare market is witnessing significant growth as the government is regularly expanding and upgrading the healthcare system to provide world-class facilities, said Dr Husnia Gargash, Founder and Shareholder at Gargash Hospital.

“UAE is becoming a hub for medical tourism as the sector registered a tremendous growth in in the last few years,” she said during an event in Dubai.

Dr Husnia said,” we have plan to expand across the UAE through our different specialty clinics in the near future.”

Gargash Hospital, the UAE’s first female Emirati-owned hospital announced exciting plans for 2022 during its second anniversary celebration on Thursday.

The event witnessed the presence of members of Royal Family from the UAE, Dr Husnia Gargash (Founder & Shareholder), Ghada Sawalmah (CEO) and other senior members of the Board and the management team.

“In the past one year, we have seen steady growth. We will look for further expansion and look forward to our continued growth in the region,” said Ghada Sawalmah, CEO – Gargash Hospital.

She said new technologies and research continues to reinforce the significance of healthcare, and the service excellence offered at Gargash serves as an essential component of delivering good health to our customers. As such, the hospital is investing aggressively in 2022, as part of its next phase of significant development. Under this plan, Gargash Hospital is upgrading its facility and expanding its range of services with addition of new specialities and technologies.  In 2021, Gargash Hospital has added few specialities and invested in state-of-the art technology to accommodate the demands of its growing patient base.  This trend will be continued in 2022 in line with our strategic expansion plans.

Ghada Sawalmaha dded, “I envision us delving deeper into the subspecialities, along the line of departments that we already have. We want to outshine at all the subspecialities. Plans for developing centres of excellence in various specialties, especially Assisted Reproductive Technology and collaboration with niche providers is also in the pipeline.”